McCormick Frank
- SEC CIK
- 0001257809
In the past year, 2 open-market sale filings worth $13.3M and no purchases.
Current role at each company
- BBIO BridgeBio Pharma, Inc.Directoras of Jun 24, 2026
- BBOT BridgeBio Oncology Therapeutics, Inc.Directoras of Jun 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $13.3M
- 2 filings
- Net
- −$13.3M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists McCormick Frank as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BBIO BridgeBio Pharma, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2025 (view filing) | Oct 29 | 2 days | McCormick FrankDirector | SSale | −198.4K | $66.58 | −$13.2M | −22.6%680.0K after | 5 lots10b5-1 |
| Oct 29, 2025 (view filing) | Oct 27 | 2 days | McCormick FrankDirector | SSale | −1.64K | $65.00 | −$106.7K | −0.2%878.3K after | 10b5-1 |
| Sep 8, 2025 (view filing) | Sep 5 | 3 days | McCormick FrankDirector | SSale | −74.0K | $53.16 | −$3.93M | −47.1%83.3K after | |
| Jun 26, 2025 (view filing) | Jun 24 | 2 days | McCormick FrankDirector | SSale | −100.0K | $44.23 | −$4.42M | −10.2%880.0K after | 10b5-1 |
| Dec 28, 2023 (view filing) | Dec 26 | 2 days | McCormick FrankDirector | SSale | −100.0K | $42.06 | −$4.21M | −13.7%627.7K after | 10b5-1 |